Item 5.02   Departure of Directors or Certain Officers; Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangements of Certain
            Officers.

On September 28, 2020, the Compensation Committee of the Board of Directors of Blonder Tongue Laboratories, Inc. (the "Company") determined to adjust the compensation of certain of the Company's executive officers. The affected officers are (i) Edward R. Grauch, President and Chief Executive Officer, (ii) Eric Skolnik, Senior Vice President, Chief Financial Officer and (iii) Ronald V. Alterio, Senior Vice President-Engineering, Chief Technology Officer. The adjustment consists of a 10% reduction in the gross salary of each of the affected executive officers (net of any amounts subject to the previously-announced Deferred Compensation Agreements between the Company and each of them), and will apply beginning on October 5, 2020 and continue thereafter through and including December 31, 2020. After December 31, 2020, in the absence of any further action taken by the Compensation Committee, the gross salary (net of any amount subject to a Deferred Compensation Agreement) of each of the affected executive officers will be reinstated to the level that existed immediately prior to the commencement of the adjustment. This action was taken as part of the Company's efforts to enhance its working capital and reduce monthly expenses, to offset, in part, the continuing impact of the COVID-19 pandemic on the Company's revenues.




                                       1

© Edgar Online, source Glimpses